CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-19 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award | +62,500 | 159,727 | ||
| 2026-02-19 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-19 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award | +62,500 | 186,964 | ||
| 2026-02-19 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-19 | Love Douglas PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +1,250,000 | 1,250,000 | ||
| 2026-02-19 | Dananberg Jamie CHIEF MEDICAL OFFICER | Grant or award | +56,250 | 129,402 | ||
| 2026-02-19 | Dananberg Jamie CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2026-02-19 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award | +62,500 | 176,265 | ||
| 2026-02-19 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-18 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | −5,290 | $5.10 | $27K | 123,487 |
| 2026-02-18 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −7,857 | $5.11 | $40K | 97,227 |
| 2026-02-18 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −6,225 | $5.10 | $32K | 124,464 |
| 2026-02-18 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | −5,290 | $5.10 | $27K | 73,152 |
| 2026-02-18 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −7,851 | $5.11 | $40K | 113,765 |
| 2025-12-30 | Carson William H. Director | Purchase 10b5-1 | +4,115 | $5.02 | $21K | 54,405 |
| 2025-12-01 | Carson William H. Director | Purchase 10b5-1 | +4,115 | $4.47 | $18K | 50,290 |
| 2025-12-01 | Choi Jung Director | Purchase | +33,000 | $4.19 | $138K | 33,000 |
| 2025-11-21 | Satter Muneer A Director | Purchase | +422,613 | $4.28 | $1.8M | 9,728,637 |
| 2025-11-20 | Satter Muneer A Director | Purchase | +400,000 | $4.48 | $1.8M | 9,306,024 |
Page 2 of 15 · 292 trades